search
Back to results

Breath-hold Cardiac Hybrid SPECT/CCTA

Primary Purpose

Coronary Artery Disease

Status
Completed
Phase
Not Applicable
Locations
Switzerland
Study Type
Interventional
Intervention
Breathhold SPECT-MPI
Standard freebreathing SPECT-MPI
Coronary CT angiography
Sponsored by
University of Zurich
About
Eligibility
Locations
Arms
Outcomes
Full info

About this trial

This is an interventional diagnostic trial for Coronary Artery Disease

Eligibility Criteria

18 Years - undefined (Adult, Older Adult)All SexesDoes not accept healthy volunteers

Inclusion Criteria:

  • Referral for cardiac hybrid SPECT/CCTA
  • Male and female subjects 18 years of age or older
  • Written informed consent by the participant after information about the project

Exclusion Criteria:

  • Contraindications for coronary CT angiography (including renal failure with a GFR <30ml/min/1.73m2, allergies to iodinated contrast agents)
  • Pregnancy or breast-feeding
  • Previous coronary revascularisation
  • Inability to follow the examination procedure (e.g. due to language barriers, severe mental disease etc

Sites / Locations

  • Department of Nuclear Medicine, University Hospital Zurich

Arms of the Study

Arm 1

Arm Type

Other

Arm Label

Breathhold SPECT-MPI vs. standard freebreathing SPECT-MPI

Arm Description

Outcomes

Primary Outcome Measures

Image quality as visually assessed on a Likert scale
Number of image artefacts

Secondary Outcome Measures

Full Information

First Posted
May 13, 2015
Last Updated
May 10, 2016
Sponsor
University of Zurich
search

1. Study Identification

Unique Protocol Identification Number
NCT02469051
Brief Title
Breath-hold Cardiac Hybrid SPECT/CCTA
Official Title
Usefulness of Breath-hold Triggered SPECT-MPI in Cardiac Hybrid SPECT/CCTA Imaging
Study Type
Interventional

2. Study Status

Record Verification Date
May 2016
Overall Recruitment Status
Completed
Study Start Date
May 2015 (undefined)
Primary Completion Date
May 2016 (Actual)
Study Completion Date
May 2016 (Actual)

3. Sponsor/Collaborators

Responsible Party, by Official Title
Sponsor
Name of the Sponsor
University of Zurich

4. Oversight

Data Monitoring Committee
Yes

5. Study Description

Brief Summary
This study aims at combining inspiration breath-hold myocardial perfusion SPECT with coronary CT angiography.

6. Conditions and Keywords

Primary Disease or Condition Being Studied in the Trial, or the Focus of the Study
Coronary Artery Disease

7. Study Design

Primary Purpose
Diagnostic
Study Phase
Not Applicable
Interventional Study Model
Single Group Assignment
Masking
None (Open Label)
Allocation
N/A
Enrollment
50 (Actual)

8. Arms, Groups, and Interventions

Arm Title
Breathhold SPECT-MPI vs. standard freebreathing SPECT-MPI
Arm Type
Other
Intervention Type
Device
Intervention Name(s)
Breathhold SPECT-MPI
Intervention Description
Respiratory triggered SPECT myocardial perfusion imaging
Intervention Type
Device
Intervention Name(s)
Standard freebreathing SPECT-MPI
Intervention Description
Clinically indicated, standard non-respiratory triggered SPECT myocardial perfusion imaging
Intervention Type
Device
Intervention Name(s)
Coronary CT angiography
Other Intervention Name(s)
CCTA
Intervention Description
Clinically indicated coronary CT angiography serving as standard of reference
Primary Outcome Measure Information:
Title
Image quality as visually assessed on a Likert scale
Time Frame
1 day
Title
Number of image artefacts
Time Frame
1 day

10. Eligibility

Sex
All
Minimum Age & Unit of Time
18 Years
Accepts Healthy Volunteers
No
Eligibility Criteria
Inclusion Criteria: Referral for cardiac hybrid SPECT/CCTA Male and female subjects 18 years of age or older Written informed consent by the participant after information about the project Exclusion Criteria: Contraindications for coronary CT angiography (including renal failure with a GFR <30ml/min/1.73m2, allergies to iodinated contrast agents) Pregnancy or breast-feeding Previous coronary revascularisation Inability to follow the examination procedure (e.g. due to language barriers, severe mental disease etc
Facility Information:
Facility Name
Department of Nuclear Medicine, University Hospital Zurich
City
Zurich
ZIP/Postal Code
8091
Country
Switzerland

12. IPD Sharing Statement

Learn more about this trial

Breath-hold Cardiac Hybrid SPECT/CCTA

We'll reach out to this number within 24 hrs